Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Jan 2026 for Adicet Bio, Inc., €3,920. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Brian Nicholas Harvey: trading record in brief
Brian Nicholas Harvey, listed as finance chief, appears in our data through filings on Adicet Bio, Inc. shares, published by SEC (Form 4). Between 1 October 2021 and 24 January 2026, the trades on record add up to 10 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 27 January 2026 with a share grant (€3,920) in Adicet Bio, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Brian Nicholas Harvey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
546 shares@ US$8.443.0% of flowCommon StockSEC:0001193125-26-024746:0
8,752 shares@ US$0.92185.9% of flowCommon StockSEC:0000950170-25-009827:0
4,320 shares@ US$2.407.3% of flowCommon StockSEC:0000950170-24-008048:0
7,096 shares@ US$1.377.1% of flowCommon StockSEC:0001209191-23-051468:0
26,100 shares0Common StockSEC:0001209191-23-005043:0
7,096 shares@ US$14.2276.8% of flowCommon StockSEC:0001209191-22-052380:0
16,000 shares0Common StockSEC:0001209191-22-044902:0
16,000 shares0Common StockSEC:0001209191-22-010479:0
16,000 shares0Common StockSEC:0001209191-22-006134:0
80,000 shares0Common StockSEC:0001209191-21-059569:0
10 of 10 declarations
